Hadly Clark (she/her)

Patient advocate, health technology nerd, art lover, dog mom, @FasterCures Director, @MilkenInstitute. Former @ASCO. Hoya Saxa. Opinions are my own.

[Hadly Clark (she/her) @HadlyClark]

📣NEW REPORT: What do #patients prefer in cancer screening and early detection? We spoke with people that have lived experience with #cancer to find out.

Read @FasterCures’ latest report to learn more. https://t.co/EpjN30Ht7q

[Hadly Clark (she/her) @HadlyClark]

Such a privilege to host a roundtable in Hong Kong w @USChinaBusiness exploring opportunities for bilateral cooperation between the US & China to address #womenscancer.

I look forward to engaging multiple partners globally to help women whose lives have been impacted by cancer.

[FasterCures @fastercures]

Cancer is a leading cause of death in the US and China. In March, @FasterCures and the US-China Business Council hosted a roundtable to explore bilateral cooperation on women’s cancers between the US and China. Read the roundtable summary here: https://t.co/bDU1ZRBjKN

[FasterCures @fastercures]

@MilkenInstitute Health's (MI Health) first newsletter was distributed today. Get updates from the MI Health team—@FasterCures, Milken Institute Public Health, Future of Aging, and Milken Institute Feeding Change. Read the MI Health newsletter here: https://t.co/cpYynfJGxK

[FasterCures @fastercures]

The Milken Institute believes the newly released US Food and Drug Administration draft guidance on Diversity Action Plans creates a pathway for diverse and inclusive #clinicaltrials.

Read our statement here: https://t.co/qgfIs8Yy3F

[Dr. Tunji Alausa @DrTunjiAlausa]

In recent years, we have witnessed an alarming rise in the burden of cancer both globally and within Nigeria. This growing health crisis underscores an urgent need to move beyond conventional treatment paradigms.

Today, I was pleased to open the “Discover, Innovate, and Collaborate” symposium on #cancer genomics, precision oncology care, and precision community health for Black populations. The occurrence of this event marks our progress towards a future where cancer care is truly personalized, where every life is valued, and every patient’s story is one of hope and triumph.

It is therefore imperative, that we embrace precision #oncology care and understand the genetic and molecular landscapes of cancers in African Black populations, which will enable the development of more effective, less toxic treatments. Precision community health will also ensure that these advancements equitably reach our populations, bridging gaps in care and fostering healthier communities.

As a nation, we have to foster collaborations with esteemed institutions, both locally and internationally to advance this cause. By pooling our resources, expertise, and innovative prowess, we can collectively lead the charge in transforming health outcomes for our communities.

I extend my thanks to Dr Malami of @NicratGov, the @MilkenInstitute, and @CherylWillmanMD @MayoClinic and @JohnsHopkins @HopkinsMedicine for their unwavering dedication to this crucial initiative.

[NICRAT @NicratGov]

DAY-1: 𝗡𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗦𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 𝗼𝗻 𝗖𝗮𝗻𝗰𝗲𝗿 𝗚𝗲𝗻𝗼𝗺𝗶𝗰𝘀, 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆 𝗖𝗮𝗿𝗲 𝗮𝗻𝗱 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗖𝗼𝗺𝗺𝘂𝗻𝗶𝘁𝘆 𝗛𝗲𝗮𝗹𝘁𝗵 𝗳𝗼𝗿 𝗕𝗹𝗮𝗰𝗸 𝗣𝗼𝗽𝘂𝗹𝗮��𝗶𝗼𝗻𝘀: 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿, 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗲 & 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗲

#nicratupdate #CancerGenomics #cancerprevention #CancerControl

[NICRAT @NicratGov]

𝗙𝗚 𝗲𝗻𝗴𝗮𝗴𝗲𝘀 𝗠𝗮𝘆𝗼 𝗰𝗹𝗶𝗻𝗶𝗰, 𝗠𝗶𝗹𝗸𝗲𝗻 𝗶𝗻𝘀𝘁𝗶𝘁𝘂𝘁���� 𝘁𝗼 𝗯𝗼𝗼𝘀𝘁 𝗰𝗮𝗻𝗰𝗲𝗿 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵

The Federal Government is collaborating with the Mayo Clinic and the Milken Institute to improve cancer research, training of oncologist, building Capacity in Clinical trials, and Cancer Genomics and Precision Oncology.

To this end the National Institute for Cancer Research and Treatment NICRAT held a symposium on Cancer Genomic, precision Oncology Care and Community health for black population, under the theme, discover, innovate and collaborate.

Cancer Genomics involves studying the genetic changes in Cancer Cells by allowing greater insights into prevention, early detection, treatment, prognosis and recurrence, while Precision Oncology is choosing treatment for cancer patients based on the DNA signature of an individual patient’s tumour.

Beyond the identification of individual targetable alterations, genomic methods measure cancer mutational load, and identify cancer- specific proteins that inform the design of personalised anti-cancer medications.

The Minister of state for health, Dr. Tunji Alausa, while declaring the Symposium open pointed out that the alarming burden of Cancer in recent times underscores an urgent need to move beyond conventional cancer treatment to innovative treatment regimen that suit the unique needs of any cancer patient.

According to Dr. Alausa, the Nigeria Government recognise the potential of precision Medicine to revolutionalise Nigeria Healthcare Value Chain, improve cancer care outcomes hence the need for the partnership with the renowned cancer facilities such as the Mayo Clinic and Milken Institute.

“It is imperative therefore that we embrace precision oncology care and understand the genetic and molecular landscape of cancers in African Black populations which will enable the development of more effective and less toxic cancer treatments in Nigeria”

“Research in cancer genomics has revolutionalised our understanding of cancer development and progression. Emerging clinical applications of Cancer genomics also includes monitoring treatment responses and characterising mechanisms of resistance. As a nation, we cannot but ensure that we are part of this revolutionary movement to improve the quality and outcome of cancer care in our population”

The Minister described the Symposium as a significant step towards a future where cancer care is truly personalised, every life valued and every patient story is one of hope and triumph.

The DG of the National Institute for Cancer Research and Treatment, Prof Usman Aliyu Malami, said the event was a step in the journey to making cancer treatment more precise, targeted and culturally relevant.

“This symposium is an opportunity to engage with World renowned cancer experts and forge strategic partnerships through shared knowledge and exchange of ideas and explore the latest advancement in cancer genomics and precision Oncology”

The Executive Director of the Mayo Clinic, Dr. Cheryl Willman, said under the partnership, they would support Nigeria to shift from treatment of late-stage Cancer to Cancer Prevention, Early Screening and Detection to save lives, as well as establish a robust Cancer registry in Nigeria.

“The creation of a National Cancer Registry in Nigeria is very important to understand which cancers are increasing in incidence, which cancers are increasing in mortality and allows the country to know how to invest in diagnostic cancer equipment”

The Symposium on” Cancer Genomic, Precision Oncology care and precision community health for black population”” was organised by NICRAT in collaboration with the Mayo Clinic and Milken Institute.

#CancerGenomics #cancerresearch #CancerTreatment

[FasterCures @fastercures]

What are the biomedical breakthroughs that will define the next decade, and what are the implications for patients, health systems, and governments? Watch this #MIGlobal discussion to learn more: https://t.co/gdVUGdLqBC

[FasterCures @fastercures]

Tune in at 4:00 pm PT/7:00 pm ET for a #MIGlobal panel discussion on the proliferation of innovative and at-home cancer screening technologies, their impact on early cancer detection, increased patient access, and effective cancer care. Stream here: https://t.co/o1f6bWB9rE

[Hadly Clark (she/her) @HadlyClark]

@tunis_rachel @iSchools Way to go, Rachel! 🎉

[FasterCures @fastercures]

#MIGlobal starts today, May 6. Join us as we reflect on what it means to “Shape Our Shared Future." Find the program and links to livestreams here: https://t.co/0wdVmYNCcq…

[FasterCures @fastercures]

Milken Institute’s 2024 Global Conference kicks off in one week. Join us as we reflect on what it means to “Shape Our Shared Future." Click below for the program and links to Livestreams: https://t.co/0wdVmYNCcq

#MIGlobal

[FasterCures @fastercures]

The White House declared April 2024 the first National Cancer Prevention and Early Detection Month. Making it the perfect time to revisit @FasterCures’ report focused on patient preferences for cancer screening. Read the report here: https://t.co/mgckX0VPMQ

[FasterCures @fastercures]

In the #PowerofIdeas series, speakers from #MIGlobal share their insights on shaping a shared future. In this essay, the CEO of @preventcancer discusses how we can get patients to preventative and early cancer screenings. Read it here: https://t.co/HrueBS1ACq

[Lisa Lacasse @LLacasseACSCAN]

New cancer diagnoses in the U.S. are expected to exceed 2 million for the first time. @AmericanCancer's report underscores the need for public policy interventions to reduce cancer disparities. @ACSCAN urges lawmakers to prioritize cancer to save lives. https://t.co/N7j0CEA4r1

[FasterCures @fastercures]

#MIHealthSummit gathered hundreds of leaders across the healthcare ecosystem, where they discussed solutions to the most pressing health issues. Discover the top 12 trends and solutions shaping the future of health in our latest brief: https://t.co/5thyDuj6Xj

[micky tripathi @mickytripathi1]

Replace "inconceivable" with "health insurance"

https://t.co/Q75MS7KWOA

[FasterCures @fastercures]

Our founder, Mike Milken, spoke about his own cancer journey and the story behind founding @FasterCures at the @ASCO Annual Meeting. Read a summary of his conversation here: https://t.co/uGrDZoS4BV

[Digestive Cancers Europe @dice_europe]

⏰It's your last chance to register for the 4th DiCE CRC Screening Summit, happening 🗓️tomorrow from 9:00 AM to 12:30 PM CET.
This year our focus is to explore the potential of tailored screening solutions. #DICECRCSummit
#RegisterNow👉https://t.co/nsnuTiyjDQ

[Mark Lewis, MD, FASCO @marklewismd]

André 3000 dropped a new album AND knows the current recommended age to initiate colon cancer screening 👏

[Hadly Clark (she/her) @HadlyClark]

Join me at the 4th DiCE CRC Screening Summit
🗓️30 November
📷 9:00 AM - 12:30 PM CET

This year, we focus on exploring the potential of tailored #CRC screening. I'll be speaking about #patientpreferences.

For additional info & registration📷https://t.co/p6HTPlsqEu ⬇️